Bacille Calmette-Guérin (BCG)

BIOLOGICAL2 trials

Sponsors

TASK Applied Science, UMC Utrecht

Conditions

COVID-19Covid19Respiratory Tract InfectionsSars-CoV2

Phase 3

BCG Vaccination for Healthcare Workers in COVID-19 Pandemic

CompletedNCT04379336

TASK Applied ScienceCOVID-19, Sars-CoV2

Start: 2020-05-04End: 2022-01-02Updated: 2022-01-25

Phase 4

Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults

CompletedNCT04537663

UMC UtrechtCovid19, Respiratory Tract Infections

Start: 2020-09-07End: 2021-07-08Updated: 2022-09-23

Related Papers

Seasonal influence on respiratory tract infection severity including COVID‐19 quantified through Markov Chain modeling

CPT Pharmacometrics & Systems Pharmacology2023-07-043 citations

Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial.

2022-05-1270 citations

Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial.

2022-04-2857 citations

Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial

Frontiers in Immunology2022-03-2250 citations